Latest filing published 28 Mar 2014 for TherapeuticsMD, Inc., €145k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +123.1%Entry US$104.00 · Close at T+365 US$232.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Nicholas Segal: trading record in brief
This profile gathers the share dealings of Nicholas Segal in TherapeuticsMD, Inc. Between 26 August 2013 and 26 March 2014, the trades on record add up to 3 filings.
Market trades split into 1 purchase (€86k) and 2 sales (€1.0M). On balance, insiders were net sellers of €958k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2014 to date brings no purchases and 2 sales.
The record was last updated on 28 March 2014 with an open-market sale (€145k) in TherapeuticsMD, Inc. The most recent open-market purchase was published on 28 August 2013, 4,821 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Nicholas Segal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 30,000 shares@ US$6.70Common StockSEC:0001387131-14-001135:0
- 185,298 shares@ US$6.70Common StockSEC:0001387131-14-001135:1
- 74,128 shares@ US$1.55Common StockSEC:0001387131-13-003196:0Canonical exit: 24 Nov 2013 (T+90)
3 of 3 declarations
